Repertoire Immune Medicines
4 clinical trials · Sponsor
◉ Watch Repertoire Immune Medicines
| Record | Firm | Date |
|---|---|---|
| An Early Phase Trial of RPTR-1-201 in Advanced Solid Tumors (NCT07293754) | Repertoire Immune Medicines | 2025-12-12 |
| RPTR-168 in Patients With Human Papillomavirus Strain 16 (HPV-16) E6/E7 Positive Tumors and Melanoma (NCT04762225) | Repertoire Immune Medicines | 2021-05-10 |
| This SCR-103 Protocol Will Permit Sites to Proactively Assess TAA, HLA and HPV-16 Status in Patients With Selected Solid Tumors to Determine Suitability for Repertoire Immune Medicines Treatment Protocols. (NCT05061940) | Repertoire Immune Medicines | 2021-05-05 |
| RPTR-147 in Patients With Selected Solid Tumors and Lymphomas (NCT03815682) | Repertoire Immune Medicines | 2018-10-24 |
Track Repertoire Immune Medicines automatically
Every clearance here is in the API, with alerts when new ones post.